Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc | WHCERegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 5.6 | |
+/-Cat | - | - | - | - | 3.6 | |
+/-B’mrk | - | - | - | - | 0.8 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 02/05/2024 | USD 5.79 | |
Day Change | -0.12% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE000L4EH2K5 | |
Fund Size (Mil) 01/05/2024 | USD 2.32 | |
Share Class Size (Mil) 01/05/2024 | USD 2.32 | |
Ongoing Charge 07/04/2023 | 0.18% |
Investment Objective: Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc | WHCE |
The investment objective of the Fund is to achieve the net total return of the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index (the "Reference Index") less fees, expenses and transaction costs. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 12/04/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Dev x-Kor LMCap ESG Enh HC NR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc | WHCE | 19/01/2024 |
|
|
Top 5 Holdings | Sector | % |
UnitedHealth Group Inc | Healthcare | 10.12 |
Eli Lilly and Co | Healthcare | 7.45 |
AbbVie Inc | Healthcare | 6.93 |
Novo Nordisk A/S Class B | Healthcare | 5.02 |
Merck & Co Inc | Healthcare | 4.48 |
Increase Decrease New since last portfolio | ||
Invesco Markets II plc - Invesco S&P World Health Care ESG UCITS ETF Acc | WHCE |